Document Type : Letter to Editor

Authors

• Mohamad Reza Namazi ^{1, 2}
• Nasrin Saki ^{1, 2}
• Maryam Hadibarhaghtalab ^{1, 2}

¹ Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran

² Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Keywords

• Ellagic acid
• adjuvant treatment
• COVID- 19 disease